Literature DB >> 18715882

CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives.

B Sinues1, A Fanlo, E Mayayo, C Carcas, J Vicente, I Arenaz, A Cebollada.   

Abstract

This study was performed to assess the influence of age, sex, smoking, and contraceptive use on CYP2A6 activity. In the metabolism of caffeine, the conversion of 1,7 dimethylxanthine (17X) to 1,7 dimethiylurate (17U) is catalyzed primarily by CYP2A6. CYP2A6 phenotype was determined by the urinary ratio 17U:17X in the interval of 4-5 h after caffeine intake in 179 healthy white Spaniards (102 women and 76 men). There were 99 non-smokers and 80 smokers. Among women, 26 were taking oral contraceptives. The age was the most important predictive factor of CYP2A6 activity (P < 0.001) with older subjects having higher activity. The influence of the gender was more modest (P = 0.07) with women exhibiting borderline increased values of the CYP2A6 marker than men. Tobacco smoking did not affect CYP2A6 activity. However, the CYP2A6 marker resulted to be strongly related to the use of oral contraceptives. The women users of oral contraceptives had higher values of CYP2A6 marker than both women not taking oral contraceptives and men (P < 0.001 in both comparisons). The results indicate that age, oral contraceptive use, and possibly gender should be controlled in epidemiological studies dealing with CYP2A6 activity and its relationship with xenobiotics exposure and genetic or pathological factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715882     DOI: 10.1177/0960327107082224

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  9 in total

Review 1.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Authors:  Gail D Anderson; Lingtak-Neander Chan
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

2.  High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.

Authors:  Eleni Aklillu; Natasa Djordjevic; Juan Antonio Carrillo; Eyasu Makonnen; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  OMICS       Date:  2013-12-31

3.  Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.

Authors:  Z Desta; Y Kreutz; A T Nguyen; L Li; T Skaar; L K Kamdem; N L Henry; D F Hayes; A M Storniolo; V Stearns; E Hoffmann; R F Tyndale; D A Flockhart
Journal:  Clin Pharmacol Ther       Date:  2011-10-05       Impact factor: 6.875

Review 4.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

5.  Use of hormonal contraceptives and smoking cessation: A preliminary report.

Authors:  Alicia M Allen; Samantha Carlson; Lynn E Eberly; Dorothy Hatsukami; Megan E Piper
Journal:  Addict Behav       Date:  2017-08-04       Impact factor: 3.913

Review 6.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

Review 7.  The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs.

Authors:  Shanna C Trenaman; Susan K Bowles; Melissa K Andrew; Kerry Goralski
Journal:  Pharmacol Res Perspect       Date:  2021-05

8.  Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver.

Authors:  Lun Yang; Yan Li; Huixiao Hong; Ching-Wei Chang; Li-Wu Guo; Beverly Lyn-Cook; Leming Shi; Baitang Ning
Journal:  J Drug Metab Toxicol       Date:  2012-07-10

9.  Generation of the Antioxidant Hydroxytyrosol from Tyrosol Present in Beer and Red Wine in a Randomized Clinical Trial.

Authors:  Natalia Soldevila-Domenech; Anna Boronat; Julian Mateus; Patricia Diaz-Pellicer; Iris Matilla; Marta Pérez-Otero; Ana Aldea-Perona; Rafael de la Torre
Journal:  Nutrients       Date:  2019-09-18       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.